Isracann Appoints Operational Expert Phil Floucault as CEO and Grants Options
20. Oktober 2021 09:00 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on...